PHAXIAM Therapeutics Quote - PHXM

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.782

Bid

1.75

Offer

1.79

Volume

1,930

1.75 Day's Range 1.79

1.50 52 Week Range 4.18

Market Cap

55.223M

Previous Close

1.788

Open

1.79

Last Trade

1.782

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

15,413

Shares Outstanding

30,989,584

Dividend Yield

PE Ratio

-2.35

Earnings Per Share (EPS)

-0.76

Revenue

1.33M

Net Profit

-23.49M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.phaxiam.com

Headquarters

Lyon, Rhone, Fra

Founded

PHAXIAM Therapeutics SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker PHXM. The last closing price for PHAXIAM Therapeutics was 1.79 €. Over the last year, PHAXIAM Therapeutics shares have traded in a share price range of 1.50 € to 4.18 €.

PHAXIAM Therapeutics currently has 30,989,584 shares in issue. The market capitalisation of PHAXIAM Therapeutics is 55.41 € million. PHAXIAM Therapeutics has a price to earnings ratio (PE ratio) of -2.35.

PHAXIAM Therapeutics annonce son calendrier financier 2025

Regulatory News: PHAXIAM Therapeutics (Euronext : PHXM – FR0011471135), société biopharmaceutique qui développe des traitements innovants pour les infections bactériennes sévères et résistantes...

PHAXIAM Therapeutics annonce des données cliniques actualisées issues de patients traités sous statut compassionnel en Europe

Des résultats cliniques prometteurs observés chez les 88 premiers patients évalués, confirmant l'innocuité et un bénéfice clinique important pour les patients Contrôle de l'infection à 3 mois...

PHAXIAM : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2024

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Regulatory News: PHAXIAM (Paris:PHXM) : Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 –...

PHAXIAM Therapeutics présente les données cliniques de l’étude pilote PhagoDAIR, dont les résultats confirment le design de l’étude clinique de Phase II GLORIA

Cette étude pilote non comparative1 incluant des patients présentant une infection sur prothèse ostéo-articulaire (PJI), a recruté 29 patients, dont 26 évaluables pour l’activité clinique sur...

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024 Article 223-16 du Règlement Général de...

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024 Article 223-16 of general regulation of French...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.018	-1	1.8	1.82	1.73	5298	1.78171463	DE
4	0.092	5.44378698225	1.69	1.85	1.62	8173	1.73857053	DE
12	0.178	11.0972568579	1.604	2.145	1.5	15413	1.74715783	DE
26	-0.198	-10	1.98	2.145	1.5	10206	1.751478	DE
52	-2.398	-57.3684210526	4.18	4.18	1.5	8920	2.136828	DE
156	0.992	125.569620253	0.79	6	0.353	24880	1.19964479	DE
260	0.992	125.569620253	0.79	6	0.353	24880	1.19964479	DE

PHXM - Frequently Asked Questions (FAQ)

What is the current PHAXIAM Therapeutics share price?

The current share price of PHAXIAM Therapeutics is 1.782 €

How many PHAXIAM Therapeutics shares are in issue?

PHAXIAM Therapeutics has 30,989,584 shares in issue

What is the market cap of PHAXIAM Therapeutics?

The market capitalisation of PHAXIAM Therapeutics is EUR 55.41M

What is the 1 year trading range for PHAXIAM Therapeutics share price?

PHAXIAM Therapeutics has traded in the range of 1.50 € to 4.18 € during the past year

What is the PE ratio of PHAXIAM Therapeutics?

The price to earnings ratio of PHAXIAM Therapeutics is -2.35

What is the cash to sales ratio of PHAXIAM Therapeutics?

The cash to sales ratio of PHAXIAM Therapeutics is 41.59

What is the reporting currency for PHAXIAM Therapeutics?

PHAXIAM Therapeutics reports financial results in EUR

What is the latest annual turnover for PHAXIAM Therapeutics?

The latest annual turnover of PHAXIAM Therapeutics is EUR 1.33M

What is the latest annual profit for PHAXIAM Therapeutics?

The latest annual profit of PHAXIAM Therapeutics is EUR -23.49M

What is the registered address of PHAXIAM Therapeutics?

The registered address for PHAXIAM Therapeutics is 60 AVENUE ROCKEFELLER, LYON, RHONE, 69008

What is the PHAXIAM Therapeutics website address?

The website address for PHAXIAM Therapeutics is www.phaxiam.com

Which industry sector does PHAXIAM Therapeutics operate in?

PHAXIAM Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLCOTCoretech 5	0.021 € (61.54%)	102.18k
AELISAelis Farma SA	3.36 € (46.09%)	24.42k
ALIMOGroupimo	0.182 € (43.31%)	484
ALCWECharwood Energy SA	3.14 € (36.52%)	10.6k
FPGUnion Tech Info	0.268 € (26.42%)	11.65k
DMSBSDiagnostic Medical Systems	0.0045 € (-35.71%)	818
ALTROTronic s Microsystems	3.90 € (-28.44%)	23
ALNMRNamR SA	0.344 € (-28.33%)	90.71k
GNROGeNeuro SA	0.1625 € (-27.46%)	1.06M
ALOKWGroupe Okwind SA	3.30 € (-20.29%)	35.38k
ATOAtos SE	0.0021 € (0.00%)	1.18B
BCPBanco Comercial Portugues SA	0.5154 € (-0.62%)	61.83M
ALCYBCybergun	0.0001 € (0.00%)	56.47M
ALVERVergnet	0.0014 € (0.00%)	19.39M
EDPEDP SA	2.901 € (-0.65%)	13.72M